Towards a New Framework for Addressing Structural Uncertainty in Health Technology Assessment Guidelines Salah GhabriIrina CleemputJean-Michel Josselin Editorial 20 December 2017 Pages: 127 - 130
Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Iñigo BermejoMatt StevensonShironjit Saha Review Article 20 September 2017 Pages: 131 - 144
Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal Nasuh C. BüyükkaramikliSaskia de GrootMaiwenn J. Al Review Article Open access 31 October 2017 Pages: 145 - 159
The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil Livia Lovato Pires de LemosAugusto Afonso Guerra JúniorFrancisco de Assis Acurcio Review Article Open access 14 November 2017 Pages: 161 - 173
Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review Mo ZhouWinter Maxwell ThayerJohn F. P. Bridges Systematic Review 03 October 2017 Pages: 175 - 187
Disease-Modifying Therapies for Multiple Sclerosis: A Systematic Literature Review of Cost-Effectiveness Studies Sergio IannazzoAnge-Christelle IlizaLouise Perrault Systematic Review 14 October 2017 Pages: 189 - 204
Systematic Review of Validity Assessments of Framingham Risk Score Results in Health Economic Modelling of Lipid-Modifying Therapies in Europe Jonas HermanssonThomas Kahan Systematic Review Open access 27 October 2017 Pages: 205 - 213
Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study Yasuhiro HagiwaraTakeru ShiroiwaHirofumi Mukai Original Research Article Open access 17 October 2017 Pages: 215 - 223
Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30 Madeleine T. KingRosalie VineyOn behalf of the MAUCa Consortium Original Research Article Open access 21 December 2017 Pages: 225 - 238
Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System Laura Catherine EdneyHossein Haji Ali AfzaliJonathan Karnon Original Research Article 22 December 2017 Pages: 239 - 252
Current UK Practices on Health Economics Analysis Plans (HEAPs): Are We Using Heaps of Them? Melina DritsakiAlastair GrayJoanna C. Thorn Research letter 06 December 2017 Pages: 253 - 257